5-Amino-1MQ
Blocks an enzyme that slows fat burning as you age. A modest fat-loss helper that stacks under a GLP-1. Mouse data, almost no human.
What it is
5-Amino-1MQ is for the person who is already dieting and training and wants a little more fat to come off, especially the stubborn kind that shows up after 40. It is a small molecule, not a peptide, and the honest expectation is a modest nudge, not a GLP-1 sized result.
The typical user is in their late 30s or older, with a metabolism that has slowed, and already doing the work. They run it under semaglutide or tirzepatide to keep fat loss going when the scale stalls, or on its own during a cut when they do not want appetite suppression. It is not a starting point for someone who has not sorted food and training; it has nothing to work with then.
Do not expect a feeling. There is no appetite drop and no stimulant buzz, which is why some people quit at week two thinking it is doing nothing. Give it the full 8 weeks with photos and a tape measure: people who respond see waist and body-fat changes from week four onward while strength holds, which is the whole pitch (fat loss without losing muscle). Some report steadier afternoon energy. If nothing has moved by week eight at 1 to 2 mg, it is not your compound.
The tiers here are subQ injection: 0.5 mg a day to start, 1 to 2 mg a day for most people, up to 5 mg for the impatient. A 10 mg vial lasts about 20 days at 0.5 mg and only 5 to 10 days at 1 to 2 mg, so a full 8-week cycle at 1 to 2 mg is six to eleven vials; budget for that before you start. Oral capsules exist, usually 50 to 100 mg, because much less survives digestion; they are convenient but you are paying for absorption you do not get. Take it at the same time daily, morning is simplest, food does not matter. Run up to 8 weeks, then 2 to 3 weeks off. It is not known to stop working; the break is caution, because the mouse studies ran for weeks and nobody has data on staying on it longer.
The science is almost all mice: diet-induced obese mice lost fat and kept lean mass when NNMT was blocked, and the enzyme itself is well characterized in people (it rises with obesity and age). Human trials of this compound are essentially nonexistent, so promising but not proven is exactly the right label, and you should price your expectations off that: a real mechanism, an unproven dose.
If you have 30 or more pounds to lose, this is the wrong first tool; semaglutide or tirzepatide will do more in a month than this does in a cycle. If you want something in the same metabolic-support lane with a bit more human signal, MOTS-c is the sibling to look at, and AOD-9604 is the gentler fat-focused option. 5-Amino-1MQ earns its place as the add-on, not the engine.
What people use it for
Fat loss and keeping muscle
Some evidenceIn diet-induced obese mice, blocking NNMT cut fat mass and body weight while lean mass held and food intake did not drop. That is the core result and it is a mouse result. In people it translates, at best, to a modest shift in composition over a cycle, not a GLP-1 sized loss.
Energy and NAD
Early daysNNMT uses up the building block your cells need to make NAD, so blocking it leaves more NAD around, which is why some users report steadier energy. Aging-mouse work showed better grip strength and recovery. Human data on any of this is close to zero, so treat energy effects as a bonus if they show up, not a reason to buy.
Insulin sensitivity and aging
Early daysNNMT activity is higher in people with obesity and insulin resistance, and animal work suggests blocking it improves glucose handling. There are no human trials showing 5-Amino-1MQ does this in a person. It is a plausible long-term angle, not a current benefit you can count on.
How it works
- Used for fat loss and metabolism, taken as a capsule
- Works by blocking a metabolism-slowing enzyme
- Mostly lab and animal research; human data is limited
- Needle-free, but still early and experimental
How people use it
Safety, in brief
Things people sometimes notice
- Nothing noticeable at all, which is normal
- Mild stomach upset in the first week
- Slightly more energy or restlessness in the afternoon for some
The full picture — stop signs and who should talk to a doctor first — is on the dosing guide.
Sources
The labels and studies behind this page. Each link opens the original on PubMed, DailyMed or ClinicalTrials.gov.
- Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice
- Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle
- Nicotinamide N-methyltransferase inhibition mimics and boosts exercise-mediated improvements in muscle function in aged mice
- Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunction